位置：成果数据库 > 期刊 > 期刊详情页
Selective inhibition on PDGFR by imatinib elicits sustained activation of ERK and downstream recepto
  • ISSN号：1019-6439
  • 期刊名称：International Journal of Oncology
  • 时间：0
  • 页码：555-569
  • 语言：英文
  • 相关项目：解析GBM基于EGFR/PI3K信号通路多模式靶向治疗靶标的研究
作者： Deng Zhenling|Li Baoxin|Dong Yucui|Xu Jiankai|Jia Limin|Tan Xiaoqing|Ren Huan|Jiang Tao|Wang Xiaohua|Rainov Nikolai G|
同期刊论文项目
解析GBM基于EGFR/PI3K信号通路多模式靶向治疗靶标的研究
期刊论文 13 会议论文 3 著作 1
同项目期刊论文
Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features.
Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in huma
Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-media
Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas
Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents
Prognostic factors influencing clinical outcomes of glioblastoma multiforme
抗血管生成靶向药物治疗恶性胶质瘤的临床研究
siRNA靶向抑制PDGFRB对人恶性脑胶质瘤细胞增殖的抑制作用
以表皮生长因子受体为靶点恶性脑胶质瘤靶向治疗研究进展
脑胶质瘤循环标志物